Financials
- Market Capitalization 14.55 M
- Employee 23
- Founded 2007
- CEO N/A
- Website www.citiuspharma.com
- Headquarter Nevada, United States
- FIGI BBG001QQH2N3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.42
ratio cours/chiffre d'affaires
3.49
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4707 | HIND Vyome Holdings, Inc. - Common Stock | 2.18 USD | 0.00% | -1.80% | -0.91% | -84.71% | 15.30 M USD | ||
| 4715 | LEXX Lexaria Bioscience Corp. - Common Stock | 0.56 USD | -5.08% | +1.82% | -6.67% | -30.86% | 13.88 M USD | ||
| 4717 | TPST Tempest Therapeutics, Inc. - Common Stock | 0.98 USD | 0.00% | 0.00% | -21.60% | -59.00% | 14.51 M USD | ||
| 4720 | PASG Passage Bio, Inc. - Common Stock | 4.50 USD | +1.35% | -6.83% | -20.63% | -49.10% | 14.44 M USD |